1FBZ
Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo anti-resorptive activity
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 14 |
Details | BINDING SITE FOR RESIDUE CC1 A 150 |
Chain | Residue |
A | ARG12 |
A | GLY93 |
B | ARG217 |
B | ARG285 |
B | HIS286 |
B | ASN289 |
A | ARG32 |
A | GLU35 |
A | SER36 |
A | HIS58 |
A | TYR59 |
A | LYS60 |
A | ILE71 |
A | SER72 |
site_id | AC2 |
Number of Residues | 15 |
Details | BINDING SITE FOR RESIDUE CC1 B 350 |
Chain | Residue |
A | GLU1 |
B | ARG212 |
B | ARG232 |
B | SER234 |
B | GLU235 |
B | SER236 |
B | CYS242 |
B | HIS258 |
B | TYR259 |
B | LYS260 |
B | ARG262 |
B | SER272 |
B | ASP292 |
B | GLY293 |
B | LEU294 |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 194 |
Details | Domain: {"description":"SH2","evidences":[{"source":"PROSITE-ProRule","id":"PRU00191","evidenceCode":"ECO:0000255"}]} |
Chain | Residue | Details |
site_id | SWS_FT_FI2 |
Number of Residues | 2 |
Details | Modified residue: {"description":"Phosphothreonine","evidences":[{"source":"PubMed","id":"19690332","evidenceCode":"ECO:0007744"}]} |
Chain | Residue | Details |
site_id | SWS_FT_FI3 |
Number of Residues | 4 |
Details | Modified residue: {"description":"Phosphoserine","evidences":[{"source":"PubMed","id":"19690332","evidenceCode":"ECO:0007744"}]} |
Chain | Residue | Details |
site_id | SWS_FT_FI4 |
Number of Residues | 2 |
Details | Modified residue: {"description":"Phosphotyrosine","evidences":[{"source":"UniProtKB","id":"P06240","evidenceCode":"ECO:0000250"}]} |
Chain | Residue | Details |